Two cases of very late stent thrombosis after implantation of a sirolimus-eluting stent presenting as AMI

International Heart Journal

Volumn 48, Issue 3, 2007, Pages 393-397

  Katayama, Toshiro ^a   Yamamoto, Tadashi ^a   Iwasaki, Yoshihiro ^a   Yano, Katsusuke ^b  

^a Nagasaki Kouseikai Hospital   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Drug eluting stent; Sirolimus; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM ANTAGONIST; DIURETIC AGENT; RAPAMYCIN; TICLOPIDINE; VOGLIBOSE;

ACUTE HEART INFARCTION; AGED; ANAMNESIS; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DIABETES MELLITUS; DRUG ELUTING STENT; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; ST SEGMENT ELEVATION; THROMBECTOMY; THROMBOSIS;

AGED; ANGINA PECTORIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY THROMBOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYOCARDIAL INFARCTION; PROSTHESIS FAILURE; REOPERATION; SIROLIMUS; STENTS; THROMBECTOMY; TIME FACTORS;

EID: 34547533555     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.393     Document Type: Article

References (14)

1. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004; 109: 1930-2.
2. Regar E, Lemos PA, Saia F, et al. Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients. Am J Cardiol 2004; 93: 1271-5.
3. Yang J, Wang N, Zhang X, et al. Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration. Int Heart J 2006; 47: 707-13.
4. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088-92.
5. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30.
6. Moreno R, Fernandez C, Hernandez R. et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies, J Am Coll Cardiol 2005; 45: 954-9.
7. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpression and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005; 45: 995-8.
8. Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-71.
9. Malenka DJ, O'Rourke D, Miller MA, et al. Cause of in-hospital death in 12,232 consecutive patients undergoing percutaneous transluminal coronary angioplasty. The Northern New England Cardiovascular Disease Study Group. Am Heart J 1999; 137: 632-8.
10. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004; 109: 701-5.
11. Virmani R, Liistro F, Stankovic G, et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 2002; 106: 2649-51.
12. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003; 108: 1701-6.
13. van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690-7.
14. FDA Advises Physicians of Adverse Events Associated with Cordis Cypher Coronary Stents. US Food and Drug Administration Public Health Web Notification 2003; T03-71.